Mesenchymal Stem Cell-Derived Extracellular Vesicles: Challenges in Clinical Applications

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Stem cell therapy, particularly using mesenchymal stem cells (MSCs), is widely explored for treating diseases and injuries.
• Therapeutic effects of MSCs are largely attributed to paracrine factors, including extracellular vesicles (EVs).
• MSC-derived EVs (MSC-EVs) exhibit regenerative and anti-inflammatory properties, offering potential advantages over MSCs.

Purpose of the Study:

• To review the therapeutic potential of MSC-EVs.
• To highlight the challenges in translating MSC-EV research from preclinical studies to clinical applications.
• To discuss critical issues for the clinical development of MSC-EVs.

Main Methods:

• Literature review of recent studies on MSC-EVs.
• Analysis of MSC-EV properties, advantages, and therapeutic roles.
• Identification of key challenges for clinical translation.

Main Results:

• MSC-EVs possess regenerative and anti-inflammatory capabilities.
• MSC-EVs offer a safer alternative to MSCs, with lower immunogenicity and reduced risks.
• Significant challenges remain in MSC-EV production, characterization, pharmacokinetics, and safety assessment.

Conclusions:

• MSC-EVs represent a promising cell-free therapeutic alternative with significant potential.
• Overcoming production, standardization, and safety hurdles is crucial for clinical implementation.
• Further research is needed to bridge the gap between preclinical findings and clinical utility of MSC-EVs.